Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients
- PMID: 21873325
- PMCID: PMC3243921
- DOI: 10.1093/arclin/acr065
Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients
Abstract
This study examined the association between recent trends in CD4 and viral loads and cognitive test performance with the expectation that recent history could predict cognitive performance. Eighty-three human immunodeficiency virus (HIV)-infected patients with a mean CD4 count of 428 copies/ml were examined in this study (62% with undetectable plasma viral load [PVL]). We investigated the relationships between nadir CD4 cell count, 1-year trends in immunologic function/PVLs, and cognitive performance across several domains using linear regression models. Nadir CD4 cell count was predictive of current executive function (p = .004). One year clinical history for CD4 cell counts and/or PVLs were predictive of executive function, attention/working memory, and learning/memory measures (p < .05). Models that combined recent clinical history trends and nadir CD4 cell counts suggested that recent clinical trends were more important in predicting current cognitive performance for all domains except executive function. This research suggests that recent CD4 and viral load history is an important predictor of current cognitive function across several cognitive domains. If validated, clinical variables and cognitive dysfunction models may improve our understanding of the dynamic relationships between disease evolution and progression and CNS involvement.
Similar articles
-
Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women.J Neurovirol. 2007 Dec;13(6):561-8. doi: 10.1080/13550280701620747. J Neurovirol. 2007. PMID: 18097887 Free PMC article.
-
CD4 nadir and neurocognitive trajectories in people living with HIV.J Neurovirol. 2024 Aug;30(4):423-433. doi: 10.1007/s13365-024-01217-8. Epub 2024 Jun 10. J Neurovirol. 2024. PMID: 38856821 Free PMC article.
-
Association of long-term patterns of depressive symptoms and attention/executive function among older men with and without human immunodeficiency virus.J Neurovirol. 2017 Aug;23(4):558-567. doi: 10.1007/s13365-017-0527-y. Epub 2017 Apr 20. J Neurovirol. 2017. PMID: 28429290 Free PMC article.
-
HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis.J Clin Exp Neuropsychol. 2018 May;40(4):357-376. doi: 10.1080/13803395.2017.1349879. Epub 2017 Jul 9. J Clin Exp Neuropsychol. 2018. PMID: 28689493 Free PMC article.
-
Immunologic and viral markers of HIV-1 disease progression: implications for dentistry.J Am Dent Assoc. 1999 Sep;130(9):1313-22. doi: 10.14219/jada.archive.1999.0401. J Am Dent Assoc. 1999. PMID: 10492538 Review.
Cited by
-
Deep Phenotyping of HIV Neurocognitive Complications Among Individuals Residing in High-Income Countries.Curr Top Behav Neurosci. 2021;50:245-269. doi: 10.1007/7854_2020_185. Curr Top Behav Neurosci. 2021. PMID: 33442841
-
Learning and Memory in Children and Adolescents With Perinatal HIV Infection and Perinatal HIV Exposure.Pediatr Infect Dis J. 2016 Jun;35(6):649-54. doi: 10.1097/INF.0000000000001131. Pediatr Infect Dis J. 2016. PMID: 26967812 Free PMC article.
-
Basal ganglia shrinkage without remarkable hippocampal atrophy in chronic aviremic HIV-positive patients.J Neurovirol. 2018 Aug;24(4):478-487. doi: 10.1007/s13365-018-0635-3. Epub 2018 Apr 23. J Neurovirol. 2018. PMID: 29687405
-
The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals.J Clin Exp Neuropsychol. 2013;35(4):421-34. doi: 10.1080/13803395.2013.783000. Epub 2013 Apr 3. J Clin Exp Neuropsychol. 2013. PMID: 23547924 Free PMC article.
-
The veterans aging cohort study index is associated with concurrent risk for neurocognitive impairment.J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):190-7. doi: 10.1097/QAI.0000000000000008. J Acquir Immune Defic Syndr. 2014. PMID: 24442225 Free PMC article.
References
-
- Ances B. M., Ellis R. J. Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology. 2007;27(1):86–92. doi:10.1055/s-2006-956759. - DOI - PubMed
-
- Baddeley A, Emslie H, Nimmo-Smith I. The Spot-the-Word test: a robust estimate of verbal intelligence based on lexical decision. Br J Clin Psychol. 1993;32(Pt 1):55–65. - PubMed
-
- Bornstein R. A., Nasrallah H. A., Para M. F., Fass R. J., Whitacre C. C., Rice R. R., Jr. Rate of CD4 decline and neuropsychological performance in HIV infection. Archives of Neurology. 1991;48:704–707. - PubMed
-
- Brew B. J. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS. 2004;18(Suppl. 1):S75–S78. - PubMed
-
- Brew B. J., Pemberton L., Cunningham P., Law M. G. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. Journal of Infectious Diseases. 1997;175(4):963–966. doi:10.1086/514001. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials